UniPharma Inc. (USA) has no DMF, CEP or site registration linked in our records. 16 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “UniPharma Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/unipharma-inc

Overview

UniPharma Inc. is a leading pharmaceutical company specializing in the development and manufacturing of innovative healthcare solutions. With a commitment to improving patient outcomes, UniPharma focuses on the development of advanced therapeutic products and technologies.

Therapeutic areas

FDA compliance signals

16 FDA enforcement records linked to this company.

  • recall — Class II2019-10-16

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-10-16

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-08-14

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-08-14

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-08-14

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

  • recall — Class II2019-05-22

    CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

For suppliers

Is this UniPharma Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.